Pages that link to "Q44657985"
Jump to navigation
Jump to search
The following pages link to Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism (Q44657985):
Displaying 50 items.
- Kinetic model for designing a cancer therapy (Q24796126) (← links)
- Numerical Modeling of Fluid Flow in Solid Tumors (Q28478450) (← links)
- A coupled discrete/continuum model for describing cancer-therapeutic transport in the lung (Q28481542) (← links)
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases (Q30471456) (← links)
- Multiscale tumor spatiokinetic model for intraperitoneal therapy (Q33574144) (← links)
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs (Q33746856) (← links)
- Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier (Q33944050) (← links)
- Effects of cellular pharmacology on drug distribution in tissues (Q34047139) (← links)
- Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime (Q34087888) (← links)
- Delivery of molecular and cellular medicine to solid tumors (Q34190339) (← links)
- Modelling and detecting tumour oxygenation levels (Q34325735) (← links)
- Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function (Q34328543) (← links)
- VEGF-VEGF receptor complexes as markers of tumor vascular endothelium (Q34328588) (← links)
- Cancer Radioimmunotherapy (Q35070045) (← links)
- Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model (Q35166891) (← links)
- Tailor-made antibody therapeutics (Q36105050) (← links)
- The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images (Q36284054) (← links)
- Nanoparticle-aptamer bioconjugates for cancer targeting. (Q36460842) (← links)
- Haemodynamic and Transport Barriers to the Treatment of Solid Tumours (Q36509071) (← links)
- Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature (Q36566561) (← links)
- Mathematical and experimental analysis of localization of anti-tumour antibody-enzyme conjugates (Q36620592) (← links)
- Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data (Q36795109) (← links)
- In vivo imaging of extraction fraction of low molecular weight mr contrast agents and perfusion rate in rodent tumors (Q36876253) (← links)
- Use of antibodies and immunoconjugates for the therapy of more accessible cancers (Q37174938) (← links)
- Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. (Q37187003) (← links)
- Combining two strategies to improve perfusion and drug delivery in solid tumors (Q37319733) (← links)
- Vascular and interstitial barriers to delivery of therapeutic agents in tumors (Q38037845) (← links)
- Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules (Q38169195) (← links)
- Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability. (Q39668471) (← links)
- Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery (Q39976098) (← links)
- Effect of fluid friction on interstitial fluid flow coupled with blood flow through solid tumor microvascular network (Q40189700) (← links)
- Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions (Q40517227) (← links)
- Antibody transport in cultured tumor cell layers (Q40842741) (← links)
- Antibody-directed targeting of the vasculature of solid tumors (Q40930942) (← links)
- Distribution of drugs following controlled delivery to the brain interstitium (Q41096789) (← links)
- 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors (Q41139696) (← links)
- Diffusion of an anti-transferrin receptor antibody in cultured murine melanoma cell layers (Q41261974) (← links)
- Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors (Q41529677) (← links)
- Factors determining antibody distribution in tumors (Q41807570) (← links)
- Towards an integrated systems-based modelling framework for drug transport and its effect on tumour cells (Q41814813) (← links)
- A mathematical model for thermosensitive liposomal delivery of Doxorubicin to solid tumour (Q41942293) (← links)
- Vascular regeneration by local growth factor release is self-limited by microvascular clearance (Q41952122) (← links)
- Effect of tumor shape and size on drug delivery to solid tumors (Q42423616) (← links)
- A tumor cord model for doxorubicin delivery and dose optimization in solid tumors (Q42542144) (← links)
- Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model (Q42573981) (← links)
- Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature (Q47211633) (← links)
- Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy (Q47987226) (← links)
- Investigating Low-Velocity Fluid Flow in Tumors with Convection-MRI. (Q50113403) (← links)
- Spatiotemporal distribution modeling of PET tracer uptake in solid tumors. (Q50539349) (← links)
- The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors (Q50579985) (← links)